bioRxivBiochemistryPreprint
Filamin-A susceptibility to calpain-mediated cleavage as a marker of dynamic conformational changes in intact platelets
Abstract
Filamin-A (FlnA), an actin-binding protein that organizes the actin cytoskeleton and mechanically links transmembrane glycoproteins to the cytoskeleton, associates with platelet receptors integrin IIb{beta}3, glycoprotein-Ib (GPIb), and integrin 2{beta}1. Fibrinogen, von Willebrand Factor (vWF) and collagen, binding to these receptors mechanically connect the extracellular matrix to the cytoskeleton. Here we identified that under standardized conditions, platelet activation and ligand binding to IIb{beta}3, GPIb, or 2{beta}1, generates reproducible patterns of FlnA cleavage after platelet lysis. We exploited this novel assay to study the impact of ligand binding and receptor activation on the platelet cytoskeleton. We identified that: i) the FlnA modification that renders it cleavable by calpain after platelet lysis, requires both ligand binding and either internal force (e.g; clot retraction) or external forces (e.g; stirring and aggregating), ii) FlnA modification depends on actin polymerization downstream of integrin IIb{beta}3 and integrin 2{beta}1, but not downstream of GPIb signaling, iii) FlnA modification is reversible in time when platelets are activated with convulxin (Cvx), collagen, von Willebrand factor (vWF) or thrombin receptor activating peptide (T6), and this reversibility correlates with platelet dissagregation, iv) in contrast to the reversible nature of platelet aggregation and FlnA modification by activation with Cvx, collagen, ristocetin or T6, when platelets are activated by thrombin the platelet do not disaggregate and FlnA remains cleavable. Our data demonstrate that IIb{beta}3, 2{beta}1 and GPIb can each exert tension on the cytoskeleton by virtue of binding ligand under conditions of shear. We further identified a unique role for IIb{beta}3-fibrin interactions in creating sustained cytoskeletal tension, with implications for thrombus stability and clot retraction.
- organism: human
- assay: proteomics
- research focus: cell signaling & trafficking
- research focus: cell type annotation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Morphometric analysis of spread platelets identifies integrin αIIbβ3-specific contractile phenotype
S. Lickert, S. Sorrentino, … I. Schoen·Scientific ReportsPeer-reviewed·Apr 3, 2018
- Inhibition of platelet function by targeting the platelet cytoskeleton via the LIMK-signaling pathway.
Juliana Antonipillai, Sheena Rigby, … Ora Bernard·bioRxiv·Oct 8, 2018
- Platelets exploit fibrillar adhesions to assemble fibronectin matrix revealing new force-regulated thrombus remodeling mechanisms
S. Lickert, K. Selcuk, … V. Vogel·bioRxiv·Apr 20, 2020
- The FH2 domain of formin proteins is critical for platelet cytoskeletal dynamics
H. L. H. Green, M. Zuidscherwoude, S. G. Thomas·bioRxiv·Mar 26, 2019
- Structural control of fibrin bioactivity by mechanical deformation
- FGF2 binds to the allosteric site (site 2) and activates integrin αIIbβ3 and FGF1 binds to site 2 but suppresses integrin activation by FGF2: A potential mechanism of anti-thrombotic action of FGF1.
Yoko K. Takada, Xueson Wu, … Yoshikazu Takada·bioRxiv·Apr 17, 2024